Request for Covid-19 Impact Assessment of this Report
The United States Insomnia Medication market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Insomnia Medication market, reaching US$ million by the year 2028. As for the Europe Insomnia Medication landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Insomnia Medication players cover Eisai, Merck, Pfizer, and Sanofi, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Insomnia Medication market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Nonbenzodiazepine Receptor Agonists
Benzodiazepine Receptor Agonists
The Selective Melatonin Receptor Agonist Ramelteon
Sedating Antidepressants
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Adults
Kids
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Eisai
Merck
Pfizer
Sanofi
Takeda
Vanda Pharmaceuticals
Astellas
Dainippon Sumitomo
ECR Pharmaceuticals (Valeant)
Flynn Pharma
Johnson & Johnson
Meda
Somnus Therapeutics
Purdue Pharma
Neurim
Minerva Neurosciences
Pernix Therapeutics
SkyePharma
Paratek Pharmaceuticals
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Insomnia Medication Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Insomnia Medication by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Insomnia Medication by Country/Region, 2017, 2022 & 2028
2.2 Insomnia Medication Segment by Type
2.2.1 Nonbenzodiazepine Receptor Agonists
2.2.2 Benzodiazepine Receptor Agonists
2.2.3 The Selective Melatonin Receptor Agonist Ramelteon
2.2.4 Sedating Antidepressants
2.3 Insomnia Medication Sales by Type
2.3.1 Global Insomnia Medication Sales Market Share by Type (2017-2022)
2.3.2 Global Insomnia Medication Revenue and Market Share by Type (2017-2022)
2.3.3 Global Insomnia Medication Sale Price by Type (2017-2022)
2.4 Insomnia Medication Segment by Application
2.4.1 Adults
2.4.2 Kids
2.5 Insomnia Medication Sales by Application
2.5.1 Global Insomnia Medication Sale Market Share by Application (2017-2022)
2.5.2 Global Insomnia Medication Revenue and Market Share by Application (2017-2022)
2.5.3 Global Insomnia Medication Sale Price by Application (2017-2022)
3 Global Insomnia Medication by Company
3.1 Global Insomnia Medication Breakdown Data by Company
3.1.1 Global Insomnia Medication Annual Sales by Company (2020-2022)
3.1.2 Global Insomnia Medication Sales Market Share by Company (2020-2022)
3.2 Global Insomnia Medication Annual Revenue by Company (2020-2022)
3.2.1 Global Insomnia Medication Revenue by Company (2020-2022)
3.2.2 Global Insomnia Medication Revenue Market Share by Company (2020-2022)
3.3 Global Insomnia Medication Sale Price by Company
3.4 Key Manufacturers Insomnia Medication Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Insomnia Medication Product Location Distribution
3.4.2 Players Insomnia Medication Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Insomnia Medication by Geographic Region
4.1 World Historic Insomnia Medication Market Size by Geographic Region (2017-2022)
4.1.1 Global Insomnia Medication Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Insomnia Medication Annual Revenue by Geographic Region
4.2 World Historic Insomnia Medication Market Size by Country/Region (2017-2022)
4.2.1 Global Insomnia Medication Annual Sales by Country/Region (2017-2022)
4.2.2 Global Insomnia Medication Annual Revenue by Country/Region
4.3 Americas Insomnia Medication Sales Growth
4.4 APAC Insomnia Medication Sales Growth
4.5 Europe Insomnia Medication Sales Growth
4.6 Middle East & Africa Insomnia Medication Sales Growth
5 Americas
5.1 Americas Insomnia Medication Sales by Country
5.1.1 Americas Insomnia Medication Sales by Country (2017-2022)
5.1.2 Americas Insomnia Medication Revenue by Country (2017-2022)
5.2 Americas Insomnia Medication Sales by Type
5.3 Americas Insomnia Medication Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Insomnia Medication Sales by Region
6.1.1 APAC Insomnia Medication Sales by Region (2017-2022)
6.1.2 APAC Insomnia Medication Revenue by Region (2017-2022)
6.2 APAC Insomnia Medication Sales by Type
6.3 APAC Insomnia Medication Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Insomnia Medication by Country
7.1.1 Europe Insomnia Medication Sales by Country (2017-2022)
7.1.2 Europe Insomnia Medication Revenue by Country (2017-2022)
7.2 Europe Insomnia Medication Sales by Type
7.3 Europe Insomnia Medication Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Insomnia Medication by Country
8.1.1 Middle East & Africa Insomnia Medication Sales by Country (2017-2022)
8.1.2 Middle East & Africa Insomnia Medication Revenue by Country (2017-2022)
8.2 Middle East & Africa Insomnia Medication Sales by Type
8.3 Middle East & Africa Insomnia Medication Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Insomnia Medication
10.3 Manufacturing Process Analysis of Insomnia Medication
10.4 Industry Chain Structure of Insomnia Medication
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Insomnia Medication Distributors
11.3 Insomnia Medication Customer
12 World Forecast Review for Insomnia Medication by Geographic Region
12.1 Global Insomnia Medication Market Size Forecast by Region
12.1.1 Global Insomnia Medication Forecast by Region (2023-2028)
12.1.2 Global Insomnia Medication Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Insomnia Medication Forecast by Type
12.7 Global Insomnia Medication Forecast by Application
13 Key Players Analysis
13.1 Eisai
13.1.1 Eisai Company Information
13.1.2 Eisai Insomnia Medication Product Offered
13.1.3 Eisai Insomnia Medication Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Eisai Main Business Overview
13.1.5 Eisai Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Insomnia Medication Product Offered
13.2.3 Merck Insomnia Medication Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Pfizer
13.3.1 Pfizer Company Information
13.3.2 Pfizer Insomnia Medication Product Offered
13.3.3 Pfizer Insomnia Medication Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Pfizer Main Business Overview
13.3.5 Pfizer Latest Developments
13.4 Sanofi
13.4.1 Sanofi Company Information
13.4.2 Sanofi Insomnia Medication Product Offered
13.4.3 Sanofi Insomnia Medication Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Sanofi Main Business Overview
13.4.5 Sanofi Latest Developments
13.5 Takeda
13.5.1 Takeda Company Information
13.5.2 Takeda Insomnia Medication Product Offered
13.5.3 Takeda Insomnia Medication Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Takeda Main Business Overview
13.5.5 Takeda Latest Developments
13.6 Vanda Pharmaceuticals
13.6.1 Vanda Pharmaceuticals Company Information
13.6.2 Vanda Pharmaceuticals Insomnia Medication Product Offered
13.6.3 Vanda Pharmaceuticals Insomnia Medication Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Vanda Pharmaceuticals Main Business Overview
13.6.5 Vanda Pharmaceuticals Latest Developments
13.7 Astellas
13.7.1 Astellas Company Information
13.7.2 Astellas Insomnia Medication Product Offered
13.7.3 Astellas Insomnia Medication Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Astellas Main Business Overview
13.7.5 Astellas Latest Developments
13.8 Dainippon Sumitomo
13.8.1 Dainippon Sumitomo Company Information
13.8.2 Dainippon Sumitomo Insomnia Medication Product Offered
13.8.3 Dainippon Sumitomo Insomnia Medication Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Dainippon Sumitomo Main Business Overview
13.8.5 Dainippon Sumitomo Latest Developments
13.9 ECR Pharmaceuticals (Valeant)
13.9.1 ECR Pharmaceuticals (Valeant) Company Information
13.9.2 ECR Pharmaceuticals (Valeant) Insomnia Medication Product Offered
13.9.3 ECR Pharmaceuticals (Valeant) Insomnia Medication Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 ECR Pharmaceuticals (Valeant) Main Business Overview
13.9.5 ECR Pharmaceuticals (Valeant) Latest Developments
13.10 Flynn Pharma
13.10.1 Flynn Pharma Company Information
13.10.2 Flynn Pharma Insomnia Medication Product Offered
13.10.3 Flynn Pharma Insomnia Medication Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Flynn Pharma Main Business Overview
13.10.5 Flynn Pharma Latest Developments
13.11 Johnson & Johnson
13.11.1 Johnson & Johnson Company Information
13.11.2 Johnson & Johnson Insomnia Medication Product Offered
13.11.3 Johnson & Johnson Insomnia Medication Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Johnson & Johnson Main Business Overview
13.11.5 Johnson & Johnson Latest Developments
13.12 Meda
13.12.1 Meda Company Information
13.12.2 Meda Insomnia Medication Product Offered
13.12.3 Meda Insomnia Medication Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Meda Main Business Overview
13.12.5 Meda Latest Developments
13.13 Somnus Therapeutics
13.13.1 Somnus Therapeutics Company Information
13.13.2 Somnus Therapeutics Insomnia Medication Product Offered
13.13.3 Somnus Therapeutics Insomnia Medication Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Somnus Therapeutics Main Business Overview
13.13.5 Somnus Therapeutics Latest Developments
13.14 Purdue Pharma
13.14.1 Purdue Pharma Company Information
13.14.2 Purdue Pharma Insomnia Medication Product Offered
13.14.3 Purdue Pharma Insomnia Medication Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Purdue Pharma Main Business Overview
13.14.5 Purdue Pharma Latest Developments
13.15 Neurim
13.15.1 Neurim Company Information
13.15.2 Neurim Insomnia Medication Product Offered
13.15.3 Neurim Insomnia Medication Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Neurim Main Business Overview
13.15.5 Neurim Latest Developments
13.16 Minerva Neurosciences
13.16.1 Minerva Neurosciences Company Information
13.16.2 Minerva Neurosciences Insomnia Medication Product Offered
13.16.3 Minerva Neurosciences Insomnia Medication Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Minerva Neurosciences Main Business Overview
13.16.5 Minerva Neurosciences Latest Developments
13.17 Pernix Therapeutics
13.17.1 Pernix Therapeutics Company Information
13.17.2 Pernix Therapeutics Insomnia Medication Product Offered
13.17.3 Pernix Therapeutics Insomnia Medication Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Pernix Therapeutics Main Business Overview
13.17.5 Pernix Therapeutics Latest Developments
13.18 SkyePharma
13.18.1 SkyePharma Company Information
13.18.2 SkyePharma Insomnia Medication Product Offered
13.18.3 SkyePharma Insomnia Medication Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 SkyePharma Main Business Overview
13.18.5 SkyePharma Latest Developments
13.19 Paratek Pharmaceuticals
13.19.1 Paratek Pharmaceuticals Company Information
13.19.2 Paratek Pharmaceuticals Insomnia Medication Product Offered
13.19.3 Paratek Pharmaceuticals Insomnia Medication Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 Paratek Pharmaceuticals Main Business Overview
13.19.5 Paratek Pharmaceuticals Latest Developments
14 Research Findings and Conclusion
Table 1. Insomnia Medication Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Insomnia Medication Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Nonbenzodiazepine Receptor Agonists
Table 4. Major Players of Benzodiazepine Receptor Agonists
Table 5. Major Players of The Selective Melatonin Receptor Agonist Ramelteon
Table 6. Major Players of Sedating Antidepressants
Table 7. Global Insomnia Medication Sales by Type (2017-2022) & (K Pcs)
Table 8. Global Insomnia Medication Sales Market Share by Type (2017-2022)
Table 9. Global Insomnia Medication Revenue by Type (2017-2022) & ($ million)
Table 10. Global Insomnia Medication Revenue Market Share by Type (2017-2022)
Table 11. Global Insomnia Medication Sale Price by Type (2017-2022) & (USD/Pcs)
Table 12. Global Insomnia Medication Sales by Application (2017-2022) & (K Pcs)
Table 13. Global Insomnia Medication Sales Market Share by Application (2017-2022)
Table 14. Global Insomnia Medication Revenue by Application (2017-2022)
Table 15. Global Insomnia Medication Revenue Market Share by Application (2017-2022)
Table 16. Global Insomnia Medication Sale Price by Application (2017-2022) & (USD/Pcs)
Table 17. Global Insomnia Medication Sales by Company (2020-2022) & (K Pcs)
Table 18. Global Insomnia Medication Sales Market Share by Company (2020-2022)
Table 19. Global Insomnia Medication Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Insomnia Medication Revenue Market Share by Company (2020-2022)
Table 21. Global Insomnia Medication Sale Price by Company (2020-2022) & (USD/Pcs)
Table 22. Key Manufacturers Insomnia Medication Producing Area Distribution and Sales Area
Table 23. Players Insomnia Medication Products Offered
Table 24. Insomnia Medication Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Insomnia Medication Sales by Geographic Region (2017-2022) & (K Pcs)
Table 28. Global Insomnia Medication Sales Market Share Geographic Region (2017-2022)
Table 29. Global Insomnia Medication Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Insomnia Medication Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Insomnia Medication Sales by Country/Region (2017-2022) & (K Pcs)
Table 32. Global Insomnia Medication Sales Market Share by Country/Region (2017-2022)
Table 33. Global Insomnia Medication Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Insomnia Medication Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Insomnia Medication Sales by Country (2017-2022) & (K Pcs)
Table 36. Americas Insomnia Medication Sales Market Share by Country (2017-2022)
Table 37. Americas Insomnia Medication Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Insomnia Medication Revenue Market Share by Country (2017-2022)
Table 39. Americas Insomnia Medication Sales by Type (2017-2022) & (K Pcs)
Table 40. Americas Insomnia Medication Sales Market Share by Type (2017-2022)
Table 41. Americas Insomnia Medication Sales by Application (2017-2022) & (K Pcs)
Table 42. Americas Insomnia Medication Sales Market Share by Application (2017-2022)
Table 43. APAC Insomnia Medication Sales by Region (2017-2022) & (K Pcs)
Table 44. APAC Insomnia Medication Sales Market Share by Region (2017-2022)
Table 45. APAC Insomnia Medication Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Insomnia Medication Revenue Market Share by Region (2017-2022)
Table 47. APAC Insomnia Medication Sales by Type (2017-2022) & (K Pcs)
Table 48. APAC Insomnia Medication Sales Market Share by Type (2017-2022)
Table 49. APAC Insomnia Medication Sales by Application (2017-2022) & (K Pcs)
Table 50. APAC Insomnia Medication Sales Market Share by Application (2017-2022)
Table 51. Europe Insomnia Medication Sales by Country (2017-2022) & (K Pcs)
Table 52. Europe Insomnia Medication Sales Market Share by Country (2017-2022)
Table 53. Europe Insomnia Medication Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Insomnia Medication Revenue Market Share by Country (2017-2022)
Table 55. Europe Insomnia Medication Sales by Type (2017-2022) & (K Pcs)
Table 56. Europe Insomnia Medication Sales Market Share by Type (2017-2022)
Table 57. Europe Insomnia Medication Sales by Application (2017-2022) & (K Pcs)
Table 58. Europe Insomnia Medication Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Insomnia Medication Sales by Country (2017-2022) & (K Pcs)
Table 60. Middle East & Africa Insomnia Medication Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Insomnia Medication Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Insomnia Medication Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Insomnia Medication Sales by Type (2017-2022) & (K Pcs)
Table 64. Middle East & Africa Insomnia Medication Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Insomnia Medication Sales by Application (2017-2022) & (K Pcs)
Table 66. Middle East & Africa Insomnia Medication Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Insomnia Medication
Table 68. Key Market Challenges & Risks of Insomnia Medication
Table 69. Key Industry Trends of Insomnia Medication
Table 70. Insomnia Medication Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Insomnia Medication Distributors List
Table 73. Insomnia Medication Customer List
Table 74. Global Insomnia Medication Sales Forecast by Region (2023-2028) & (K Pcs)
Table 75. Global Insomnia Medication Sales Market Forecast by Region
Table 76. Global Insomnia Medication Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Insomnia Medication Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Insomnia Medication Sales Forecast by Country (2023-2028) & (K Pcs)
Table 79. Americas Insomnia Medication Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Insomnia Medication Sales Forecast by Region (2023-2028) & (K Pcs)
Table 81. APAC Insomnia Medication Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Insomnia Medication Sales Forecast by Country (2023-2028) & (K Pcs)
Table 83. Europe Insomnia Medication Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Insomnia Medication Sales Forecast by Country (2023-2028) & (K Pcs)
Table 85. Middle East & Africa Insomnia Medication Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Insomnia Medication Sales Forecast by Type (2023-2028) & (K Pcs)
Table 87. Global Insomnia Medication Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Insomnia Medication Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Insomnia Medication Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Insomnia Medication Sales Forecast by Application (2023-2028) & (K Pcs)
Table 91. Global Insomnia Medication Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Insomnia Medication Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Insomnia Medication Revenue Market Share Forecast by Application (2023-2028)
Table 94. Eisai Basic Information, Insomnia Medication Manufacturing Base, Sales Area and Its Competitors
Table 95. Eisai Insomnia Medication Product Offered
Table 96. Eisai Insomnia Medication Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 97. Eisai Main Business
Table 98. Eisai Latest Developments
Table 99. Merck Basic Information, Insomnia Medication Manufacturing Base, Sales Area and Its Competitors
Table 100. Merck Insomnia Medication Product Offered
Table 101. Merck Insomnia Medication Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 102. Merck Main Business
Table 103. Merck Latest Developments
Table 104. Pfizer Basic Information, Insomnia Medication Manufacturing Base, Sales Area and Its Competitors
Table 105. Pfizer Insomnia Medication Product Offered
Table 106. Pfizer Insomnia Medication Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 107. Pfizer Main Business
Table 108. Pfizer Latest Developments
Table 109. Sanofi Basic Information, Insomnia Medication Manufacturing Base, Sales Area and Its Competitors
Table 110. Sanofi Insomnia Medication Product Offered
Table 111. Sanofi Insomnia Medication Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 112. Sanofi Main Business
Table 113. Sanofi Latest Developments
Table 114. Takeda Basic Information, Insomnia Medication Manufacturing Base, Sales Area and Its Competitors
Table 115. Takeda Insomnia Medication Product Offered
Table 116. Takeda Insomnia Medication Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 117. Takeda Main Business
Table 118. Takeda Latest Developments
Table 119. Vanda Pharmaceuticals Basic Information, Insomnia Medication Manufacturing Base, Sales Area and Its Competitors
Table 120. Vanda Pharmaceuticals Insomnia Medication Product Offered
Table 121. Vanda Pharmaceuticals Insomnia Medication Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 122. Vanda Pharmaceuticals Main Business
Table 123. Vanda Pharmaceuticals Latest Developments
Table 124. Astellas Basic Information, Insomnia Medication Manufacturing Base, Sales Area and Its Competitors
Table 125. Astellas Insomnia Medication Product Offered
Table 126. Astellas Insomnia Medication Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 127. Astellas Main Business
Table 128. Astellas Latest Developments
Table 129. Dainippon Sumitomo Basic Information, Insomnia Medication Manufacturing Base, Sales Area and Its Competitors
Table 130. Dainippon Sumitomo Insomnia Medication Product Offered
Table 131. Dainippon Sumitomo Insomnia Medication Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 132. Dainippon Sumitomo Main Business
Table 133. Dainippon Sumitomo Latest Developments
Table 134. ECR Pharmaceuticals (Valeant) Basic Information, Insomnia Medication Manufacturing Base, Sales Area and Its Competitors
Table 135. ECR Pharmaceuticals (Valeant) Insomnia Medication Product Offered
Table 136. ECR Pharmaceuticals (Valeant) Insomnia Medication Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 137. ECR Pharmaceuticals (Valeant) Main Business
Table 138. ECR Pharmaceuticals (Valeant) Latest Developments
Table 139. Flynn Pharma Basic Information, Insomnia Medication Manufacturing Base, Sales Area and Its Competitors
Table 140. Flynn Pharma Insomnia Medication Product Offered
Table 141. Flynn Pharma Insomnia Medication Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 142. Flynn Pharma Main Business
Table 143. Flynn Pharma Latest Developments
Table 144. Johnson & Johnson Basic Information, Insomnia Medication Manufacturing Base, Sales Area and Its Competitors
Table 145. Johnson & Johnson Insomnia Medication Product Offered
Table 146. Johnson & Johnson Insomnia Medication Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 147. Johnson & Johnson Main Business
Table 148. Johnson & Johnson Latest Developments
Table 149. Meda Basic Information, Insomnia Medication Manufacturing Base, Sales Area and Its Competitors
Table 150. Meda Insomnia Medication Product Offered
Table 151. Meda Insomnia Medication Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 152. Meda Main Business
Table 153. Meda Latest Developments
Table 154. Somnus Therapeutics Basic Information, Insomnia Medication Manufacturing Base, Sales Area and Its Competitors
Table 155. Somnus Therapeutics Insomnia Medication Product Offered
Table 156. Somnus Therapeutics Insomnia Medication Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 157. Somnus Therapeutics Main Business
Table 158. Somnus Therapeutics Latest Developments
Table 159. Purdue Pharma Basic Information, Insomnia Medication Manufacturing Base, Sales Area and Its Competitors
Table 160. Purdue Pharma Insomnia Medication Product Offered
Table 161. Purdue Pharma Insomnia Medication Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 162. Purdue Pharma Main Business
Table 163. Purdue Pharma Latest Developments
Table 164. Neurim Basic Information, Insomnia Medication Manufacturing Base, Sales Area and Its Competitors
Table 165. Neurim Insomnia Medication Product Offered
Table 166. Neurim Insomnia Medication Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 167. Neurim Main Business
Table 168. Neurim Latest Developments
Table 169. Minerva Neurosciences Basic Information, Insomnia Medication Manufacturing Base, Sales Area and Its Competitors
Table 170. Minerva Neurosciences Insomnia Medication Product Offered
Table 171. Minerva Neurosciences Insomnia Medication Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 172. Minerva Neurosciences Main Business
Table 173. Minerva Neurosciences Latest Developments
Table 174. Pernix Therapeutics Basic Information, Insomnia Medication Manufacturing Base, Sales Area and Its Competitors
Table 175. Pernix Therapeutics Insomnia Medication Product Offered
Table 176. Pernix Therapeutics Insomnia Medication Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 177. Pernix Therapeutics Main Business
Table 178. Pernix Therapeutics Latest Developments
Table 179. SkyePharma Basic Information, Insomnia Medication Manufacturing Base, Sales Area and Its Competitors
Table 180. SkyePharma Insomnia Medication Product Offered
Table 181. SkyePharma Insomnia Medication Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 182. SkyePharma Main Business
Table 183. SkyePharma Latest Developments
Table 184. Paratek Pharmaceuticals Basic Information, Insomnia Medication Manufacturing Base, Sales Area and Its Competitors
Table 185. Paratek Pharmaceuticals Insomnia Medication Product Offered
Table 186. Paratek Pharmaceuticals Insomnia Medication Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 187. Paratek Pharmaceuticals Main Business
Table 188. Paratek Pharmaceuticals Latest Developments
List of Figures
Figure 1. Picture of Insomnia Medication
Figure 2. Insomnia Medication Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Insomnia Medication Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Insomnia Medication Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Insomnia Medication Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Nonbenzodiazepine Receptor Agonists
Figure 10. Product Picture of Benzodiazepine Receptor Agonists
Figure 11. Product Picture of The Selective Melatonin Receptor Agonist Ramelteon
Figure 12. Product Picture of Sedating Antidepressants
Figure 13. Global Insomnia Medication Sales Market Share by Type in 2021
Figure 14. Global Insomnia Medication Revenue Market Share by Type (2017-2022)
Figure 15. Insomnia Medication Consumed in Adults
Figure 16. Global Insomnia Medication Market: Adults (2017-2022) & (K Pcs)
Figure 17. Insomnia Medication Consumed in Kids
Figure 18. Global Insomnia Medication Market: Kids (2017-2022) & (K Pcs)
Figure 19. Global Insomnia Medication Sales Market Share by Application (2017-2022)
Figure 20. Global Insomnia Medication Revenue Market Share by Application in 2021
Figure 21. Insomnia Medication Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Insomnia Medication Revenue Market Share by Company in 2021
Figure 23. Global Insomnia Medication Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Insomnia Medication Revenue Market Share by Geographic Region in 2021
Figure 25. Global Insomnia Medication Sales Market Share by Region (2017-2022)
Figure 26. Global Insomnia Medication Revenue Market Share by Country/Region in 2021
Figure 27. Americas Insomnia Medication Sales 2017-2022 (K Pcs)
Figure 28. Americas Insomnia Medication Revenue 2017-2022 ($ Millions)
Figure 29. APAC Insomnia Medication Sales 2017-2022 (K Pcs)
Figure 30. APAC Insomnia Medication Revenue 2017-2022 ($ Millions)
Figure 31. Europe Insomnia Medication Sales 2017-2022 (K Pcs)
Figure 32. Europe Insomnia Medication Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Insomnia Medication Sales 2017-2022 (K Pcs)
Figure 34. Middle East & Africa Insomnia Medication Revenue 2017-2022 ($ Millions)
Figure 35. Americas Insomnia Medication Sales Market Share by Country in 2021
Figure 36. Americas Insomnia Medication Revenue Market Share by Country in 2021
Figure 37. United States Insomnia Medication Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Insomnia Medication Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Insomnia Medication Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Insomnia Medication Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Insomnia Medication Sales Market Share by Region in 2021
Figure 42. APAC Insomnia Medication Revenue Market Share by Regions in 2021
Figure 43. China Insomnia Medication Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Insomnia Medication Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Insomnia Medication Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Insomnia Medication Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Insomnia Medication Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Insomnia Medication Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Insomnia Medication Sales Market Share by Country in 2021
Figure 50. Europe Insomnia Medication Revenue Market Share by Country in 2021
Figure 51. Germany Insomnia Medication Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Insomnia Medication Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Insomnia Medication Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Insomnia Medication Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Insomnia Medication Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Insomnia Medication Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Insomnia Medication Revenue Market Share by Country in 2021
Figure 58. Egypt Insomnia Medication Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Insomnia Medication Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Insomnia Medication Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Insomnia Medication Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Insomnia Medication Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Insomnia Medication in 2021
Figure 64. Manufacturing Process Analysis of Insomnia Medication
Figure 65. Industry Chain Structure of Insomnia Medication
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...